Income Statement (TTM)
Filament Health Corp. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 2 | 2 | 1 | 0 | 0 |
| Change (%) | 19.69 | 87.40 | 0.00 | -27.43 | 115.49 | 273.87 | 13.98 | 1.94 | -12.86 | -71.42 | -31.53 | 10.85 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | |||||||||||||
| Change (%) | |||||||||||||
| % of Revenue | |||||||||||||
| Gross Operating Profit | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 2 | 2 | 1 | 0 | 0 |
| Change (%) | 19.69 | 87.40 | 0.00 | -27.43 | 115.49 | 273.87 | 13.98 | 1.94 | -12.86 | -71.42 | -31.53 | 10.85 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| SG&A | 5 | 5 | 5 | 4 | 4 | 4 | 6 | 5 | 5 | 5 | 4 | 4 | 3 |
| Change (%) | -8.38 | -4.66 | -9.25 | -2.12 | 8.76 | 28.47 | -3.40 | -7.08 | -9.92 | -19.92 | -3.88 | -9.48 | |
| % of Revenue | 3,201.47 | 2,450.57 | 1,246.74 | 1,131.40 | 1,526.07 | 770.20 | 264.66 | 224.30 | 204.44 | 211.35 | 592.21 | 831.36 | 678.83 |
| R&D | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Change (%) | 0.04 | -42.85 | 0.09 | -1.24 | -4.63 | 0.32 | 8.01 | -0.20 | -5.50 | -35.99 | -2.97 | -17.90 | |
| % of Revenue | 903.20 | 754.88 | 230.22 | 230.42 | 313.59 | 138.79 | 37.24 | 35.29 | 34.55 | 37.46 | 83.90 | 118.90 | 88.05 |
| OpEx | 7 | 6 | 6 | 5 | 5 | 5 | 7 | 7 | 6 | 6 | 4 | 4 | 4 |
| Change (%) | -6.76 | -12.85 | -7.50 | -1.87 | 6.29 | 23.30 | -1.89 | -5.91 | -8.95 | -21.46 | -3.57 | -10.00 | |
| % of Revenue | 4,228.93 | 3,294.19 | 1,532.01 | 1,417.05 | 1,916.28 | 945.16 | 311.70 | 268.29 | 247.62 | 258.74 | 710.99 | 1,001.33 | 812.94 |
| Operating Income | -7 | -6 | -5 | -5 | -5 | -5 | -5 | -4 | -4 | -3 | -4 | -4 | -3 |
| Change (%) | -7.40 | -15.98 | -8.03 | 0.07 | 0.27 | -6.35 | -9.39 | -10.58 | -6.30 | 10.00 | 1.00 | -12.32 | |
| % of Revenue | -4,128.93 | -3,194.19 | -1,432.01 | -1,317.05 | -1,816.28 | -845.16 | -211.70 | -168.29 | -147.62 | -158.74 | -610.99 | -901.33 | -712.94 |
| Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Change (%) | 13.95 | 176.10 | 34.94 | 26.23 | 27.94 | -6.92 | 7.11 | 9.59 | -22.81 | -29.64 | -41.66 | -31.37 | |
| % of Revenue | -36.12 | -34.39 | -50.66 | -68.36 | -118.92 | -70.60 | -17.58 | -16.52 | -17.76 | -15.73 | -38.73 | -33.00 | -20.43 |
| Net Income | -7 | -7 | -16 | -16 | -16 | -16 | -5 | -5 | -4 | -4 | -5 | -5 | -4 |
| Change (%) | -5.65 | 146.11 | -2.07 | 0.34 | 0.32 | -67.22 | -6.52 | -9.88 | -7.44 | 19.76 | -1.21 | -9.57 | |
| % of Revenue | -4,364.04 | -3,439.93 | -4,517.55 | -4,424.10 | -6,117.48 | -2,848.08 | -249.75 | -204.83 | -181.08 | -192.34 | -805.98 | -1,162.92 | -948.70 |
Source: Capital IQ
